Ethnicity
At-Home Colorectal Cancer Testing and Follow-Up Vary by Ethnicity
Doctors were significantly less likely to order colorectal cancer screening with the at-home test Cologuard (Exact Sciences Corp) for Black patient...
Gilead Sciences's (GILD) Kite Announces Yescarta CAR T-cell Therapy Demonstrates Consistent Survival Outcomes and Safety in Real-World Setting Rega...
News and research before you hear about it on CNBC and others. Claim your 1-week free trial to StreetInsider Premium here.
— Black or Africa...
Axi-Cel Shows Favorable Outcomes in Large B-Cell Lymphoma Regardless of Race, Ethnicity
In patients with large B-cell lymphoma (LBCL), treatment with axicabtagene ciloleucel (axi-cel;Yescarta; Kite Pharma, Gilead) was associated with a...
Yescarta® CAR T-cell Therapy Demonstrates Consistent Survival Outcomes and Safety in Real-World Setting Regardless of Race and Ethnicity
Yescarta® CAR T-cell Therapy Demonstrates Consistent Survival Outcomes and Safety in Real-World Setting Regardless of Race and Ethnicity
— ...
Colorado’s Medicaid data on race and ethnicity deemed ‘poor’ quality by CMS - State of Reform
CMS recently released its assessments of states’ Medicaid administrative data and Colorado is one of 17 states where race and ethnicity data were o...
Race, ethnicity, phycological factors, and COVID-19 vaccine hesitancy during the COVID-19 pandemic
We examined the associations between perceived risk, perceived severity, and fear of contracting COVID-19 and vaccine acceptance among different et...
Trending Topics
Features
- Drive Toolkit
Download and distribute powerful vaccination QI resources for your community.
- Health Champions
Sign up now to support health equity and sustainable health outcomes in your community.
- Cancer Early Detection
MCED tests use a simple blood draw to screen for many kinds of cancer at once.
- PR
FYHN is a bridge connecting health information providers to BIPOC communities in a trusted environment.
- Medicare
Discover an honest look at our Medicare system.
- Alliance for Representative Clinical Trials
ARC was launched to create a network of community clinicians to diversify and bring clinical trials to communities of color and other communities that have been underrepresented.
- Reducing Patient Risk
The single most important purpose of our healthcare system is to reduce patient risk for an acute event.
